Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds.

Wang E, Sorolla MA, Krishnan PDG, Sorolla A.

Biomolecules. 2020 Feb 6;10(2). pii: E248. doi: 10.3390/biom10020248. Review.

2.

Sensitizing endometrial cancer to ionizing radiation by multi-tyrosine kinase inhibition.

Wang E, Sorolla A.

J Gynecol Oncol. 2019 Nov 5. doi: 10.3802/jgo.2020.31.e29. [Epub ahead of print]

3.

Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics.

Sorolla A, Wang E, Golden E, Duffy C, Henriques ST, Redfern AD, Blancafort P.

Oncogene. 2020 Feb;39(6):1167-1184. doi: 10.1038/s41388-019-1056-3. Epub 2019 Oct 21. Review.

4.

Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers.

Kretzmann JA, Evans CW, Moses C, Sorolla A, Kretzmann AL, Wang E, Ho D, Hackett MJ, Dessauvagie BF, Smith NM, Redfern AD, Waryah C, Norret M, Iyer KS, Blancafort P.

Chem Sci. 2019 Jun 27;10(33):7718-7727. doi: 10.1039/c9sc01432b. eCollection 2019 Sep 7.

5.

Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides.

Sorolla A, Wang E, Clemons TD, Evans CW, Plani-Lam JH, Golden E, Dessauvagie B, Redfern AD, Swaminathan-Iyer K, Blancafort P.

Nanomedicine. 2019 Aug;20:102003. doi: 10.1016/j.nano.2019.04.006. Epub 2019 May 2.

6.

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers.

Wang E, Sorolla A, Cunningham PT, Bogdawa HM, Beck S, Golden E, Dewhurst RE, Florez L, Cruickshank MN, Hoffmann K, Hopkins RM, Kim J, Woo AJ, Watt PM, Blancafort P.

Oncogene. 2019 Jan;38(1):140-150. doi: 10.1038/s41388-018-0421-y. Epub 2018 Aug 3.

7.

Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy.

Devarasetty M, Wang E, Soker S, Skardal A.

Biofabrication. 2017 Jun 7;9(2):021002. doi: 10.1088/1758-5090/aa7484.

PMID:
28589925
8.

Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases.

Wang EC, Huang AJ, Huang KE, McTyre ER, Lo HW, Watabe K, Metheny-Barlow L, Laxton AW, Tatter SB, Strowd RE, Chan MD, Page BR.

J Clin Neurosci. 2017 Sep;43:6-10. doi: 10.1016/j.jocn.2017.04.033. Epub 2017 May 13.

PMID:
28511975
9.

Gamma Knife radiosurgery for brain metastases from gastrointestinal primary.

Page BR, Wang EC, White L, McTyre E, Peiffer A, Alistar A, Mu F, Loganathan A, Bourland JD, Laxton AW, Tatter SB, Chan MD.

J Med Imaging Radiat Oncol. 2017 Aug;61(4):522-527. doi: 10.1111/1754-9485.12584. Epub 2017 Jan 31.

PMID:
28139076
10.

Artist's Statement: Reflection.

Wang E.

Acad Med. 2016 Dec;91(12):1597. doi: 10.1097/ACM.0000000000001434. No abstract available.

PMID:
29408847
11.

Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery.

Tian X, Lara H, Wagner KT, Saripalli S, Hyder SN, Foote M, Sethi M, Wang E, Caster JM, Zhang L, Wang AZ.

Nanoscale. 2015 Dec 21;7(47):20211-9. doi: 10.1039/c5nr05869d. Epub 2015 Nov 17.

12.

Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors.

Wang EC, Min Y, Palm RC, Fiordalisi JJ, Wagner KT, Hyder N, Cox AD, Caster JM, Tian X, Wang AZ.

Biomaterials. 2015 May;51:208-215. doi: 10.1016/j.biomaterials.2015.02.015. Epub 2015 Feb 19.

13.

Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity.

Caster JM, Sethi M, Kowalczyk S, Wang E, Tian X, Nabeel Hyder S, Wagner KT, Zhang YA, Kapadia C, Man Au K, Wang AZ.

Nanoscale. 2015 Feb 14;7(6):2805-11. doi: 10.1039/c4nr07102f.

14.

Three-dimensional (3D) structure prediction of the American and African oil-palms β-ketoacyl-[ACP] synthase-II protein by comparative modelling.

Wang E, Chinni S, Bhore SJ.

Bioinformation. 2014 Mar 19;10(3):130-7. doi: 10.6026/97320630010130. eCollection 2014.

15.

Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity.

Sethi M, Sukumar R, Karve S, Werner ME, Wang EC, Moore DT, Kowalczyk SR, Zhang L, Wang AZ.

Nanoscale. 2014 Feb 21;6(4):2321-2327. doi: 10.1039/c3nr05961h. Epub 2014 Jan 14.

16.

Nanoparticles and their applications in cell and molecular biology.

Wang EC, Wang AZ.

Integr Biol (Camb). 2014 Jan;6(1):9-26. doi: 10.1039/c3ib40165k. Review.

17.

Differential cell responses to nanoparticle docetaxel and small molecule docetaxel at a sub-therapeutic dose range.

Wang EC, Sinnott R, Werner ME, Sethi M, Whitehurst AW, Wang AZ.

Nanomedicine. 2014 Feb;10(2):321-8. doi: 10.1016/j.nano.2013.07.012. Epub 2013 Aug 3.

18.

Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer.

Werner ME, Cummings ND, Sethi M, Wang EC, Sukumar R, Moore DT, Wang AZ.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):463-468. doi: 10.1016/j.ijrobp.2013.02.009.

19.

Computational analysis of common bean (Phaseolus vulgaris L., genotype BAT93) lycopene β-cyclase and β-carotene hydroxylase gene's cDNA.

Bhore SJ, Amelia K, Wang E, Priyadharsini S, Shah FH.

Bioinformation. 2013;9(4):197-206. doi: 10.6026/97320630009197. Epub 2013 Feb 21.

20.

Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery.

Karve S, Werner ME, Sukumar R, Cummings ND, Copp JA, Wang EC, Li C, Sethi M, Chen RC, Pacold ME, Wang AZ.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):8230-5. doi: 10.1073/pnas.1120508109. Epub 2012 Apr 30.

Supplemental Content

Loading ...
Support Center